COST vs MRK: Which Is the Better Buy?

Side-by-side comparison of Costco Wholesale Corporation and Merck & Co., Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-08.
Costco Wholesale Corporation Β· Consumer Defensive
$947.50
-1.4% upside to fair value
Grade C High Quality
VS
Merck & Co., Inc. Β· Healthcare
$113.87
-12.1% upside to fair value
Grade D High Quality
QuantHub Verdict
COST has more upside to fair value (-1.4%). MRK trades at a lower forward P/E (32.0x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric COST MRK
Current Price $947.50 $113.87
Fair Value Estimate $933.84 $100.14
Upside to Fair Value -1.4% -12.1%
Market Cap $420.2B $281.2B
Forward P/E 47.6x 32.0x
EV / EBITDA 28.3x 17.3x
Price / Sales 1.4x 4.3x
Price / FCF 47.7x 19.9x
Revenue Growth YoY +11.6% +4.3%
Gross Margin 12.9% 75.9%
Operating Margin 3.8% 27.6%
Return on Equity 28.3% 17.9%
Dividend Yield 0% 0%
FCF Yield 2.1% 5.02%
Analyst Consensus Buy Hold
Investment Thesis
COST β€” Costco Wholesale Corporation
Costco Wholesale Corporation operates as a membership-only warehouse club offering a wide range of merchandise at low prices. The company exhibits high business quality with a durable competitive moat driven by cost advantages, strong brand loyalty, and efficient operations, reflected in a robust ROE of 28.3% and solid revenue growth of 11.6% in the most recent quarter. Despite these strengths, t…
MRK β€” Merck & Co., Inc.
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
Metric COST MRK
Zone Low $700.38 $75.11
Zone High $793.76 $85.12
In Buy Zone? No No
← COST Research    MRK Research β†’    All Research